GET THE APP

Synthesis, characterization, DNA binding and anticancer property of cis chlorodimethylsulphoxide(S)bis(1,10-phenanthroline) ruthenium(II) chloride | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Synthesis, characterization, DNA binding and anticancer property of cis chlorodimethylsulphoxide(S)bis(1,10-phenanthroline) ruthenium(II) chloride

Author(s): P. Hazarika, J. Deka, S. Bhola, R. K. Bhola, C. Medhi and O. K. Medhi

The six coordinated Ruthenium complex of formula [Ru(phen)2(dmso)Cl]+Cl- (cis-chlorodimethylsulphoxide-Sbis( 1,10-phenanthroline) ruthenium (II) chloride) has been prepared, and characterized structure on the basis of spectroscopic data, such as FT-IR, 1H NMR and UV-Vis spectroscopy. The molecular structure of the complex determined by X-ray diffraction studies is found to be octahedral. Also the bond lengths, bond angles and dihedral angles are found complementary to octahedral structure. Further studies on the binding of this complex with Calf Thymus DNA (CT-DNA) have been carried out by using UV-visible spectroscopy, electrochemical and gel electrophoresis studies. The evidences of CT-DNA binding with this complex have been indicated from these studies. The anticancer activity of this compound against Dalton’s lymphoma (in vitro and in vivo) is found promising.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry